A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases
To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with ir...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
D. N. Andreev [verfasserIn] D. T. Dicheva [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Russisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Медицинский совет - Remedium Group LLC, 2019, (2020), 5, Seite 87-95 |
|---|---|
| Übergeordnetes Werk: |
year:2020 ; number:5 ; pages:87-95 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.21518/2079-701X-2020-5-87-95 |
|---|
| Katalog-ID: |
DOAJ084403543 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ084403543 | ||
| 003 | DE-627 | ||
| 005 | 20230505014414.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230311s2020 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.21518/2079-701X-2020-5-87-95 |2 doi | |
| 035 | |a (DE-627)DOAJ084403543 | ||
| 035 | |a (DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 0 | |a D. N. Andreev |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. | ||
| 650 | 4 | |a functional gastrointestinal diseases | |
| 650 | 4 | |a functional dyspepsia | |
| 650 | 4 | |a irritable bowel syndrome | |
| 650 | 4 | |a intestinal permeability | |
| 650 | 4 | |a intestinal barrier | |
| 650 | 4 | |a tight junctions | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a D. T. Dicheva |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Медицинский совет |d Remedium Group LLC, 2019 |g (2020), 5, Seite 87-95 |w (DE-627)1760607460 |x 26585790 |7 nnns |
| 773 | 1 | 8 | |g year:2020 |g number:5 |g pages:87-95 |
| 856 | 4 | 0 | |u https://doi.org/10.21518/2079-701X-2020-5-87-95 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.med-sovet.pro/jour/article/view/5608 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2079-701X |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2658-5790 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |j 2020 |e 5 |h 87-95 | ||
| author_variant |
d n a dna d t d dtd |
|---|---|
| matchkey_str |
article:26585790:2020----::becitenetnlemaiiysfcooeiptoeeiofntoa |
| hierarchy_sort_str |
2020 |
| publishDate |
2020 |
| allfields |
10.21518/2079-701X-2020-5-87-95 doi (DE-627)DOAJ084403543 (DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. functional gastrointestinal diseases functional dyspepsia irritable bowel syndrome intestinal permeability intestinal barrier tight junctions Medicine R D. T. Dicheva verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2020), 5, Seite 87-95 (DE-627)1760607460 26585790 nnns year:2020 number:5 pages:87-95 https://doi.org/10.21518/2079-701X-2020-5-87-95 kostenfrei https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9 kostenfrei https://www.med-sovet.pro/jour/article/view/5608 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2020 5 87-95 |
| spelling |
10.21518/2079-701X-2020-5-87-95 doi (DE-627)DOAJ084403543 (DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. functional gastrointestinal diseases functional dyspepsia irritable bowel syndrome intestinal permeability intestinal barrier tight junctions Medicine R D. T. Dicheva verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2020), 5, Seite 87-95 (DE-627)1760607460 26585790 nnns year:2020 number:5 pages:87-95 https://doi.org/10.21518/2079-701X-2020-5-87-95 kostenfrei https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9 kostenfrei https://www.med-sovet.pro/jour/article/view/5608 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2020 5 87-95 |
| allfields_unstemmed |
10.21518/2079-701X-2020-5-87-95 doi (DE-627)DOAJ084403543 (DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. functional gastrointestinal diseases functional dyspepsia irritable bowel syndrome intestinal permeability intestinal barrier tight junctions Medicine R D. T. Dicheva verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2020), 5, Seite 87-95 (DE-627)1760607460 26585790 nnns year:2020 number:5 pages:87-95 https://doi.org/10.21518/2079-701X-2020-5-87-95 kostenfrei https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9 kostenfrei https://www.med-sovet.pro/jour/article/view/5608 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2020 5 87-95 |
| allfieldsGer |
10.21518/2079-701X-2020-5-87-95 doi (DE-627)DOAJ084403543 (DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. functional gastrointestinal diseases functional dyspepsia irritable bowel syndrome intestinal permeability intestinal barrier tight junctions Medicine R D. T. Dicheva verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2020), 5, Seite 87-95 (DE-627)1760607460 26585790 nnns year:2020 number:5 pages:87-95 https://doi.org/10.21518/2079-701X-2020-5-87-95 kostenfrei https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9 kostenfrei https://www.med-sovet.pro/jour/article/view/5608 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2020 5 87-95 |
| allfieldsSound |
10.21518/2079-701X-2020-5-87-95 doi (DE-627)DOAJ084403543 (DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9 DE-627 ger DE-627 rakwb rus D. N. Andreev verfasserin aut A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. functional gastrointestinal diseases functional dyspepsia irritable bowel syndrome intestinal permeability intestinal barrier tight junctions Medicine R D. T. Dicheva verfasserin aut In Медицинский совет Remedium Group LLC, 2019 (2020), 5, Seite 87-95 (DE-627)1760607460 26585790 nnns year:2020 number:5 pages:87-95 https://doi.org/10.21518/2079-701X-2020-5-87-95 kostenfrei https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9 kostenfrei https://www.med-sovet.pro/jour/article/view/5608 kostenfrei https://doaj.org/toc/2079-701X Journal toc kostenfrei https://doaj.org/toc/2658-5790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 2020 5 87-95 |
| language |
Russian |
| source |
In Медицинский совет (2020), 5, Seite 87-95 year:2020 number:5 pages:87-95 |
| sourceStr |
In Медицинский совет (2020), 5, Seite 87-95 year:2020 number:5 pages:87-95 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
functional gastrointestinal diseases functional dyspepsia irritable bowel syndrome intestinal permeability intestinal barrier tight junctions Medicine R |
| isfreeaccess_bool |
true |
| container_title |
Медицинский совет |
| authorswithroles_txt_mv |
D. N. Andreev @@aut@@ D. T. Dicheva @@aut@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
1760607460 |
| id |
DOAJ084403543 |
| language_de |
russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ084403543</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505014414.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2020 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21518/2079-701X-2020-5-87-95</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ084403543</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">D. N. Andreev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">functional gastrointestinal diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">functional dyspepsia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">irritable bowel syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intestinal permeability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intestinal barrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tight junctions</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. T. Dicheva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Медицинский совет</subfield><subfield code="d">Remedium Group LLC, 2019</subfield><subfield code="g">(2020), 5, Seite 87-95</subfield><subfield code="w">(DE-627)1760607460</subfield><subfield code="x">26585790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2020</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:87-95</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21518/2079-701X-2020-5-87-95</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.med-sovet.pro/jour/article/view/5608</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-701X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2020</subfield><subfield code="e">5</subfield><subfield code="h">87-95</subfield></datafield></record></collection>
|
| author |
D. N. Andreev |
| spellingShingle |
D. N. Andreev misc functional gastrointestinal diseases misc functional dyspepsia misc irritable bowel syndrome misc intestinal permeability misc intestinal barrier misc tight junctions misc Medicine misc R A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases |
| authorStr |
D. N. Andreev |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760607460 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
26585790 |
| topic_title |
A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases functional gastrointestinal diseases functional dyspepsia irritable bowel syndrome intestinal permeability intestinal barrier tight junctions |
| topic |
misc functional gastrointestinal diseases misc functional dyspepsia misc irritable bowel syndrome misc intestinal permeability misc intestinal barrier misc tight junctions misc Medicine misc R |
| topic_unstemmed |
misc functional gastrointestinal diseases misc functional dyspepsia misc irritable bowel syndrome misc intestinal permeability misc intestinal barrier misc tight junctions misc Medicine misc R |
| topic_browse |
misc functional gastrointestinal diseases misc functional dyspepsia misc irritable bowel syndrome misc intestinal permeability misc intestinal barrier misc tight junctions misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Медицинский совет |
| hierarchy_parent_id |
1760607460 |
| hierarchy_top_title |
Медицинский совет |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760607460 |
| title |
A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases |
| ctrlnum |
(DE-627)DOAJ084403543 (DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9 |
| title_full |
A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases |
| author_sort |
D. N. Andreev |
| journal |
Медицинский совет |
| journalStr |
Медицинский совет |
| lang_code |
rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
txt |
| container_start_page |
87 |
| author_browse |
D. N. Andreev D. T. Dicheva |
| format_se |
Elektronische Aufsätze |
| author-letter |
D. N. Andreev |
| doi_str_mv |
10.21518/2079-701X-2020-5-87-95 |
| author2-role |
verfasserin |
| title_sort |
breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases |
| title_auth |
A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases |
| abstract |
To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. |
| abstractGer |
To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. |
| abstract_unstemmed |
To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
5 |
| title_short |
A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases |
| url |
https://doi.org/10.21518/2079-701X-2020-5-87-95 https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9 https://www.med-sovet.pro/jour/article/view/5608 https://doaj.org/toc/2079-701X https://doaj.org/toc/2658-5790 |
| remote_bool |
true |
| author2 |
D. T. Dicheva |
| author2Str |
D. T. Dicheva |
| ppnlink |
1760607460 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.21518/2079-701X-2020-5-87-95 |
| up_date |
2024-07-03T22:49:07.418Z |
| _version_ |
1803599947941019648 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ084403543</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505014414.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2020 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.21518/2079-701X-2020-5-87-95</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ084403543</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ569cc4b9f0f244f79608e915ebad3fb9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">D. N. Andreev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A breach in the intestinal permeability as a factor of etiopathogenesis of functional gastrointestinal diseases</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">To date the mechanisms of etiopathogenesis of functional gastrointestinal diseases continue to be actively studied. By now, alteration of the components of the intestinal epithelial tight junctions supporting the intestinal barrier integrity has been identified in several studies in patients with irritable bowel syndrome and functional dyspepsia (FD). Characteristic changes in patients with IBS compared with healthy controls include decreased expression of ZO-1 protein and occludin in mucosal biopsy specimens from various parts of the colon. On the other hand, the analysis of duodenal biopsy specimens shows similar changes in patients with FD. The causative factor of these changes continues to be studied. In fact, experimental and clinical studies conducted to date have demonstrated that there are factors that affect adversely the structural and functional stability of intestinal tight junctions. Regardless of the initiating factor, the compromise of tight junctions results in the breach of permeability of the intestinal mucosa and the entry of various intraluminal factors into the proper mucous plate, contributing to the activation of resident immunocompetent cells. Due to the production of cytokines and other biologically active substances, the latter lead to sensitization of nerve endings, thereby inducing the development of visceral hypersensitivity phenomenon and alteration of the motor behaviours of the gastrointestinal tract. The literature describes the phenomenon of activation of a local inflammatory response in patients with functional gastrointestinal diseases as “low-grade inflammation”. These data update the need to consider restoration of the intestinal mucosal barrier in patients with diseases in question as a therapeutic target. This review article systematizes data on this problem.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">functional gastrointestinal diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">functional dyspepsia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">irritable bowel syndrome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intestinal permeability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">intestinal barrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tight junctions</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. T. Dicheva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Медицинский совет</subfield><subfield code="d">Remedium Group LLC, 2019</subfield><subfield code="g">(2020), 5, Seite 87-95</subfield><subfield code="w">(DE-627)1760607460</subfield><subfield code="x">26585790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">year:2020</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:87-95</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.21518/2079-701X-2020-5-87-95</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/569cc4b9f0f244f79608e915ebad3fb9</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.med-sovet.pro/jour/article/view/5608</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2079-701X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-5790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="j">2020</subfield><subfield code="e">5</subfield><subfield code="h">87-95</subfield></datafield></record></collection>
|
| score |
7.4018335 |